BRIP1 and breast cancer: Five rare variants in <i>BRIP1/FANCJ</i>, initially identified in ovarian cancer (OC) or breast cancer (BC) cases by the adult hereditary cancer clinics, were investigated for their candidacy as clinically relevant variants.